David Hirsch - 23 May 2024 Form 4 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 May 2024, 18:59:56 UTC
Prior SEC filing
05 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean M. Wirtjes, Attorney-in-Fact for David Hirsch

Key filing fact

David Hirsch filed Form 4 for RAPID MICRO BIOSYSTEMS, INC. (RPID) on 28 May 2024.

Key facts

  • This page summarizes David Hirsch's Form 4 filing for RAPID MICRO BIOSYSTEMS, INC. (RPID).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 28 May 2024, 18:59.

Change

  • Previous filing in this sequence was filed on 05 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPID transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+14,300
Change %
Price
$0.000000
Shares after
14,300
Date
23 May 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPID transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+28,650
Change %
Price
$0.000000
Shares after
28,650
Date
23 May 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
28,650
Exercise price
$0.8200
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted stock units ("RSUs") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date.

Footnote F2

The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .